Guiding the Molnupiravir Tablet Formulation Using Physiologically Based Biopharmaceutics Modeling and Successfully
Thomas Morrow1, Nicole Jarvi1, Madeline Halota1
1Development Sciences and Clinical Supply , MRL, Merck & Co., Inc., Rahway, NJ, 07065, USA.
Physiologically Based Biopharmaceutics Models (PBBMs) aid drug development by defining bioequivalence safe spaces. This approach enhances regulatory flexibility and supports clinically relevant specifications for products like molnupiravir.
Area of Science:
- Pharmacokinetics and Drug Metabolism
- Pharmaceutical Sciences
- Regulatory Science
Background:
- Physiologically Based Biopharmaceutics Models (PBBMs) are increasingly accepted regulatory tools.
- PBBMs assist in establishing drug product quality specifications.
- Molnupiravir development utilized PBBMs for formulation and bioequivalence studies.
Purpose of the Study:
- To demonstrate the application of PBBMs in molnupiravir drug product development.
- To calculate bioequivalence safe spaces for capsule and tablet formulations.
- To inform regulatory strategies and define clinically relevant specifications.
Main Methods:
- PBBM data inputs, model development, and validation using clinical study data.
- Calculation of bioequivalence safe space and dissolution knowledge space.
- Utilizing predictive error analysis for Cmax and AUC, and z-factor for dissolution.
Main Results:
- Predictive errors for Cmax and AUC were less than 25%.
- PBBM successfully informed bioequivalence studies and formulation selection for molnupiravir.
- A wider dissolution space was established, allowing for greater post-approval flexibility.
Conclusions:
- PBBMs are valuable for drug product development, formulation selection, and regulatory flexibility.
- The use of PBBMs can lead to the approval of clinically relevant specifications.
- Widening the dissolution knowledge space through PBBMs offers significant advantages for scale-up and post-approval changes.
Related Concept Videos
Factors Influencing Drug Absorption: Pharmaceutical Parameters
In Vitro Drug Dissolution: Compendial Testing Models I
In Vitro Drug Dissolution: Alternative Methods
In Vitro Drug Dissolution: Compendial Testing Models II
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
Factors Influencing Drug Absorption: Drug Dissolution

